A, C., T, H., AC, E., C, F., M, S., R, B., . . . K, S. (2021). Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?
Citación estilo ChicagoA, Cechová, et al. Should Patients With Phosphomannomutase 2-CDG (PMM2-CDG) Be Screened for Adrenal Insufficiency? 2021.
Cita MLAA, Cechová, et al. Should Patients With Phosphomannomutase 2-CDG (PMM2-CDG) Be Screened for Adrenal Insufficiency? 2021.
Precaución: Estas citas no son 100% exactas.